Cargando…
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
The severe acute respiratory syndrome (SARS)-like coronavirus disease (COVID-19) is caused by SARS-CoV-2 and has been a serious threat to global public health with limited treatment. Cellular heparan sulfate (HS) has been found to bind SARS-CoV-2 spike protein (SV2-S) and co-operate with cell surfac...
Autores principales: | Yue, Jingwen, Jin, Weihua, Yang, Hua, Faulkner, John, Song, Xuehong, Qiu, Hong, Teng, Michael, Azadi, Parastoo, Zhang, Fuming, Linhardt, Robert J., Wang, Lianchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231436/ https://www.ncbi.nlm.nih.gov/pubmed/34179075 http://dx.doi.org/10.3389/fmolb.2021.649575 |
Ejemplares similares
-
The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics
por: Eilts, Friederike, et al.
Publicado: (2023) -
The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology
por: Mah, Dylan, et al.
Publicado: (2021) -
Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus
por: Yan, Lufeng, et al.
Publicado: (2021) -
Spike-heparan sulfate interactions in SARS-CoV-2 infection
por: Kearns, Fiona L., et al.
Publicado: (2022) -
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro
por: Kwon, Paul S., et al.
Publicado: (2020)